Article Dans Une Revue The Lancet Respiratory Medicine Année : 2025

Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients

1 Cleveland Clinic
2 North Carolina Central University [Durham]
3 HPPIT - Hypertension pulmonaire : physiopathologie et innovation thérapeutique
4 Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
5 ERN LUNG - European Reference Network on rare respiratory diseases (ERN-LUNG) = Réseau européen de référence sur les maladies rares respiratoires (ERN-LUNG)
6 MHH - Medizinische Hochschule Hannover = Hannover Medical School
7 German Center for Lung Research - DZL [Munich, Germany]
8 BREATH - Biomedical Research in Endstage and Obstructive Lung Disease Hannover
9 URMC - University of Rochester Medical Center
10 Mayo Clinic College of Medicine
11 Johns Hopkins University School of Medicine [Baltimore]
12 Vanderbilt University Medical Center [Nashville]
13 Perelman School of Medicine
14 University of Michigan Medical School [Ann Arbor]
15 Universitätsklinikum Frankfurt
16 Goethe University Frankfurt = Goethe-Universität Frankfurt am Main
17 UMCG - University Medical Center Groningen [Groningen]
18 University of Groningen [Groningen]
19 Inova Fairfax Hospital
20 FDA - U.S. Food and Drug Administration
21 Brigham and Women's Hospital [Boston]
22 University of Alberta
23 DCAC - Défaillance Cardiovasculaire Aiguë et Chronique
24 CIC-P - Centre d'investigation clinique plurithématique Pierre Drouin [Nancy]
25 INI-CRCT - Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy]
26 Cardiovascular & Renal Clinical Trialists - CRCT - French-Clinical Research Infrastructure Network - F-CRIN [Paris]
27 Houston Methodist Hospital [Houston, TX, USA]
Fichier principal
Vignette du fichier
Future treatment paradigm in PAH-LRM.pdf (464 Ko) Télécharger le fichier

Dates et versions

hal-04994290 , version 1 (17-03-2025)

Licence

Identifiants

Citer

Franck F Rahaghi, Marc Humbert, Marius M Hoeper, R James White, Robert P Frantz, et al.. Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients. The Lancet Respiratory Medicine, 2025, 13 (4), pp.364-370. ⟨10.1016/S2213-2600(24)00425-9⟩. ⟨hal-04994290⟩
83 Consultations
72 Téléchargements

Altmetric

Partager

  • More